Feasibility of Individualized Therapy for Recurrent Glioblastoma
Phase 1
Active, not recruiting
- Conditions
- Recurrent Glioblastoma
- Interventions
- Drug: Individualized therapy
- First Posted Date
- 2018-09-21
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Jennifer Clarke
- Target Recruit Count
- 30
- Registration Number
- NCT03681028
- Locations
- 🇺🇸
University of California San Francisco, San Francisco, California, United States
© Copyright 2025. All Rights Reserved by MedPath